Results 21 to 30 of about 90,078 (248)

Generation of a human induced pluripotent stem cell line from a patient with dent disease

open access: yesStem Cell Research, 2023
Dent disease, an X-linked tubular disorder, is a rare condition that leads to low-molecular-weight proteinuria, hypercalciuria, kidney stones, and chronic kidney disease.
Xianying Fang   +12 more
doaj   +1 more source

Gunther’s Disease: Esthetic Management of Erythrodontia; 1-year Follow-up [PDF]

open access: yesInternational Journal of Prosthodontics and Restorative Dentistry, 2023
Intrinsic tooth stains are more permanent in nature than extrinsic stains and can be divided into two types systemic and local. Erythrodontia is reddish-brown or reddish-black discoloration of teeth caused due to congenital erythropoietic porphyria (CEP)
Pranjal Sharma   +2 more
doaj   +1 more source

Mutation Update of theCLCN5Gene Responsible for Dent Disease 1 [PDF]

open access: yesHuman Mutation, 2015
Dent disease is a rare X-linked tubulopathy characterized by low molecular weight proteinuria, hypercalciuria, nephrocalcinosis and/or nephrolithiasis, progressive renal failure, and variable manifestations of other proximal tubule dysfunctions.
Mansour-Hendili, Lamisse   +67 more
openaire   +5 more sources

A case of Type 1 Dent disease presenting with isolated persistant proteinuria [PDF]

open access: yesTürk Pediatri Arşivi, 2018
Dent disease is a rare X-linked recessive tubular disorder, characterized by the triad of low molecular-weight proteinuria, hypercalciuria, nephrocalcinosis and/or nephrolithiasis. It is caused by mutations in the CLCN5 gene or OCRL gene. Thirty to 80% of affected males develop end-stage kidney disease between the ages of 30 and 50 years. Some children
Güngör, Tülin   +6 more
openaire   +2 more sources

Lentiviral vector mediated gene therapy for type I Dent disease ameliorates Dent disease-like phenotypes for three months in ClC-5 null mice

open access: yesMolecular Therapy: Methods & Clinical Development, 2022
Type 1 Dent disease is caused by changes in chloride voltage-gated channel 5 (CLCN5) gene on chromosome X, which causes the lack or dysfunction of chloride channel ClC-5.
Manish Kumar Yadav   +3 more
doaj   +1 more source

Living Kidney Donation in a Type 1 Dent’s Disease Patient from His Mother [PDF]

open access: yesKidney and Blood Pressure Research, 2019
<b><i>Introduction:</i></b> Dent’s disease is a rare X-linked recessive disorder that manifests in childhood or early adulthood and can lead to end-stage renal disease (ESRD). It occurs in males, who are hemizygous. In patients who develop ESRD, a deceased donor kidney transplant cures the disease.
Gambaro G.   +6 more
openaire   +6 more sources

Dent-2 disease with a Bartter-like phenotype caused by the Asp631Glu mutation in the OCRL gene

open access: yesBMC Nephrology, 2022
Background Dent disease is an X-linked disorder characterized by low molecular weight proteinuria (LMWP), hypercalciuria, nephrolithiasis and chronic kidney disease (CKD).
Eleni Drosataki   +9 more
doaj   +1 more source

Characterization of pre-mRNA Splicing Defects Caused by CLCN5 and OCRL Mutations and Identification of Novel Variants Associated with Dent Disease

open access: yesBiomedicines, 2023
Dent disease (DD) is an X-linked renal tubulopathy characterized by low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, nephrolithiasis and progressive renal failure.
Glorián Mura-Escorche   +4 more
doaj   +1 more source

A retrospective case-control analysis of the outpatient expenditures for western medicine and dental treatment modalities in CKD patients in Taiwan. [PDF]

open access: yesPLoS ONE, 2014
BACKGROUND: To determine if expenditures for dentistry (DENT) correlate with severity of chronic kidney disease (CKD). METHODS: A total of 10,457 subjects were enrolled from January 2008 to December 2010, divided into three groups: healthy control (HC ...
Ren-Yeong Huang   +4 more
doaj   +1 more source

Phenotypic spectrum and antialbuminuric response to angiotensin converting enzyme inhibitor and angiotensin receptor blocker therapy in pediatric Dent disease

open access: yesMolecular Genetics & Genomic Medicine, 2020
Background To characterize the phenotypic spectrum and assess the antialbuminuric response to angiotensin converting enzyme (ACE) inhibitor and/or angiotensin receptor blocker (ARB) therapy in a cohort of children with Dent disease. Methods The patients’
Haiyue Deng   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy